Innate Immune Receptors in Host Responses to Neisseria
Project Number2R01AI046613-06A1
Contact PI/Project LeaderINGALLS, ROBIN R
Awardee OrganizationBOSTON MEDICAL CENTER
Description
Abstract Text
DESCRIPTION (provided by applicant): The human pathogen Neisseria gonorrhoeae produces an array of diseases ranging from urethritis and cervicitis to pelvic inflammatory disease. Early events in the establishment of infection involve interactions between N. gonorrhoeae and the mucosal surface, which lead to the local release of inflammatory mediators. Because of this, it is important to identify the bacterial factors and host cell components that contribute to inflammation. The innate immune system is the first line of defense against invading microorganisms. Toll-like receptors (TLRs) are a part of this innate immune defense, recognizing conserved microbial patterns and initiating signal transduction pathways that direct the inflammatory response. These germ-line encoded proteins are expressed to varying degrees in both professional and non-professional immune cells. Epithelial cells that line the mucosal surface are often the initial site of contact for microorganisms, making them responsible for alerting adjacent epithelium and the underlying immune cells of the potential danger posed by an infectious challenge. Little is known about the mechanism of epithelial cell activation by pathogens, and the receptors and secondary mediators involved in this regulated response. We hypothesize that the interactions between STD pathogens and the TLRs expressed on mucosal epithelial cells are responsible for initiating and coordinating the subsequent inflammatory response. Our previous work established that cervical epithelial cells fail to express the LPS receptor TLR4 and the associated molecule MD-2. In contrast, they express a variety of other TLRs that appear to be functionally capable of recognizing their cognate ligands. This includes TLR2 for the recognition of bacterial lipoproteins and TLR9 for the recognition of bacterial DNA. The goal of this proposal is to identify the innate immune receptors in the urogenital tract that are responsible for the recognition of N. gonorrhoeae and the initiation of the immune response. We aim to: (1) characterize the interactions between TLR2 and gonococcal lipoproteins during gonococcal infections; (2) examine the role of bacterial DNA and TLR9 signaling in epithelial cell responses to Neisseria; (3) examine the signaling pathways activated during gonococcal infection; and (4) examine the role played by TLRs in gonococcal pathogenesis using the mouse model for genital tract infection in defined TLR mutants.
National Institute of Allergy and Infectious Diseases
CFDA Code
856
DUNS Number
005492160
UEI
JZ8RQC4EMDZ5
Project Start Date
15-January-2000
Project End Date
31-January-2010
Budget Start Date
01-August-2005
Budget End Date
31-January-2006
Project Funding Information for 2005
Total Funding
$168,726
Direct Costs
$112,500
Indirect Costs
$56,226
Year
Funding IC
FY Total Cost by IC
2005
National Institute of Allergy and Infectious Diseases
$168,726
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 2R01AI046613-06A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R01AI046613-06A1
Patents
No Patents information available for 2R01AI046613-06A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R01AI046613-06A1
Clinical Studies
No Clinical Studies information available for 2R01AI046613-06A1
News and More
Related News Releases
No news release information available for 2R01AI046613-06A1
History
No Historical information available for 2R01AI046613-06A1
Similar Projects
No Similar Projects information available for 2R01AI046613-06A1